GS-5734

GS-5734 (Remdesivir) is a monophosphoramidate prodrug of adenosine analogue that exhibits antiviral activity against multiple variants of EBOV (EC50=70-140 nM) and other filoviruses (EC50=0.019-1.48 uM) in cell-based assays; suppresses EBOV replication and protects 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and pathophysiological markers.Ebola Virus Infection Phase 2 Clinical (In Vitro) :Remdesivir (GS-5734) inhibits murine hepatitis virus (MHV) with an EC50 of 30 nM, and blocks SARS-CoV and MERS-CoV in HAE cells with EC50s of both 74 nM in HAE cells after treatment for 24 h.

Product Specifications

CAS Number

1809249-37-3

Product Name Alternative

GS 5734 | GS5734 | Remdesivir

Purity

>98% (HPLC)

Solubility

DMSO : ≥ 125 mg/mL 207.44 mM

Smiles

CCC (CC) COC ([C@H] (C) N[P@] (OC[C@H]1O[C@] (C2=CC=C3N2N=CC=C3N) (C#N) [C@H] (O) [C@@H]1O) (OC4=CC=CC=C4) =O) =O

Molecular Formula

C28H36N5O8P

Molecular Weight

601.597

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Other Product Names

2-ethylbutyl ((S) - (((2R,3S,4R,5R) -5- (4-aminopyrrolo[1,2-b]pyridazin-7-yl) -5-cyano-3,4-dihydroxytetrahydrofuran-2-yl) methoxy) (phenoxy) phosphoryl) -L-alaninate